TEXAS CAPITAL BANCSHARES INC (TCBI)

US88224Q1076 - Common Stock

76.77  -0.01 (-0.01%)

After market: 76.77 0 (0%)

Fundamental Rating

3

TCBI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 406 industry peers in the Banks industry. The financial health of TCBI is average, but there are quite some concerns on its profitability. TCBI is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

TCBI had positive earnings in the past year.
In the past year TCBI had a positive cash flow from operations.
In the past 5 years TCBI has always been profitable.
TCBI had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

TCBI's Return On Assets of 0.03% is on the low side compared to the rest of the industry. TCBI is outperformed by 91.09% of its industry peers.
The Return On Equity of TCBI (0.28%) is worse than 91.34% of its industry peers.
Industry RankSector Rank
ROA 0.03%
ROE 0.28%
ROIC N/A
ROA(3y)0.8%
ROA(5y)0.69%
ROE(3y)7.67%
ROE(5y)7.16%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TCBI's Profit Margin of 1.05% is on the low side compared to the rest of the industry. TCBI is outperformed by 91.09% of its industry peers.
In the last couple of years the Profit Margin of TCBI has declined.
TCBI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 1.05%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y43.94%
PM growth 5Y-10.96%
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

TCBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
TCBI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TCBI has less shares outstanding
TCBI has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of TCBI is 1.12, which is an excellent value as it means it would take TCBI, only 1.12 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.12, TCBI is in the better half of the industry, outperforming 76.49% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that TCBI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.20, TCBI is in line with its industry, outperforming 49.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.12
Altman-Z N/A
ROIC/WACCN/A
WACC15.89%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The earnings per share for TCBI have decreased strongly by -10.83% in the last year.
The Earnings Per Share has been decreasing by -9.37% on average over the past years.
TCBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.98%.
TCBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.61% yearly.
EPS 1Y (TTM)-10.83%
EPS 3Y47.2%
EPS 5Y-9.37%
EPS Q2Q%37.29%
Revenue 1Y (TTM)-33.98%
Revenue growth 3Y0.67%
Revenue growth 5Y1.61%
Sales Q2Q%-53.81%

3.2 Future

Based on estimates for the next years, TCBI will show a very strong growth in Earnings Per Share. The EPS will grow by 22.45% on average per year.
Based on estimates for the next years, TCBI will show a small growth in Revenue. The Revenue will grow by 6.20% on average per year.
EPS Next Y-72.5%
EPS Next 2Y27.42%
EPS Next 3Y22.45%
EPS Next 5YN/A
Revenue Next Year-4.35%
Revenue Next 2Y5.81%
Revenue Next 3Y6.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.92 indicates a rather expensive valuation of TCBI.
Compared to the rest of the industry, the Price/Earnings ratio of TCBI indicates a rather expensive valuation: TCBI more expensive than 80.94% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of TCBI to the average of the S&P500 Index (27.73), we can say TCBI is valued inline with the index average.
The Price/Forward Earnings ratio is 13.36, which indicates a correct valuation of TCBI.
TCBI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. TCBI is more expensive than 63.37% of the companies in the same industry.
TCBI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 23.92
Fwd PE 13.36

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TCBI is valued cheaper than 89.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.02
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as TCBI's earnings are expected to grow with 22.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.42%
EPS Next 3Y22.45%

0

5. Dividend

5.1 Amount

No dividends for TCBI!.
Industry RankSector Rank
Dividend Yield N/A

TEXAS CAPITAL BANCSHARES INC

NASDAQ:TCBI (12/20/2024, 8:00:00 PM)

After market: 76.77 0 (0%)

76.77

-0.01 (-0.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-17 2024-10-17/bmo
Earnings (Next)01-16 2025-01-16/amc
Inst Owners94.42%
Inst Owner Change-2.33%
Ins Owners3.54%
Ins Owner Change5.1%
Market Cap3.55B
Analysts69.47
Price Target84.58 (10.17%)
Short Float %2.6%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)12.84%
DP184.21%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.89%
Min EPS beat(2)-8.93%
Max EPS beat(2)68.72%
EPS beat(4)1
Avg EPS beat(4)-5.44%
Min EPS beat(4)-57.08%
Max EPS beat(4)68.72%
EPS beat(8)3
Avg EPS beat(8)-6.57%
EPS beat(12)4
Avg EPS beat(12)-6.54%
EPS beat(16)6
Avg EPS beat(16)-5.45%
Revenue beat(2)0
Avg Revenue beat(2)-26.8%
Min Revenue beat(2)-51.56%
Max Revenue beat(2)-2.04%
Revenue beat(4)0
Avg Revenue beat(4)-14.76%
Min Revenue beat(4)-51.56%
Max Revenue beat(4)-0.78%
Revenue beat(8)2
Avg Revenue beat(8)3.28%
Revenue beat(12)5
Avg Revenue beat(12)2.13%
Revenue beat(16)6
Avg Revenue beat(16)0.63%
PT rev (1m)3.38%
PT rev (3m)27.12%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)2.64%
EPS NY rev (1m)0.92%
EPS NY rev (3m)-70.22%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)-4.44%
Valuation
Industry RankSector Rank
PE 23.92
Fwd PE 13.36
P/S 3.97
P/FCF 6.02
P/OCF 5.45
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)3.21
EY4.18%
EPS(NY)5.75
Fwd EY7.49%
FCF(TTM)12.75
FCFY16.61%
OCF(TTM)14.07
OCFY18.33%
SpS19.36
BVpS72.58
TBVpS72.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.03%
ROE 0.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.05%
GM N/A
FCFM 65.86%
ROA(3y)0.8%
ROA(5y)0.69%
ROE(3y)7.67%
ROE(5y)7.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y43.94%
PM growth 5Y-10.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.12
Debt/EBITDA N/A
Cap/Depr 126.25%
Cap/Sales 6.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 6277.43%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC15.89%
ROIC/WACCN/A
Cap/Depr(3y)23.27%
Cap/Depr(5y)23.66%
Cap/Sales(3y)0.97%
Cap/Sales(5y)0.94%
Profit Quality(3y)176.33%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.83%
EPS 3Y47.2%
EPS 5Y-9.37%
EPS Q2Q%37.29%
EPS Next Y-72.5%
EPS Next 2Y27.42%
EPS Next 3Y22.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-33.98%
Revenue growth 3Y0.67%
Revenue growth 5Y1.61%
Sales Q2Q%-53.81%
Revenue Next Year-4.35%
Revenue Next 2Y5.81%
Revenue Next 3Y6.2%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y88.16%
FCF growth 3Y-48.64%
FCF growth 5YN/A
OCF growth 1Y100.05%
OCF growth 3Y-47.88%
OCF growth 5YN/A